Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 10 - Jul 15
Promo Codes Available:
For Your Every Summer RSVP, with Code: SUMMER15
Description
A BTK inhibitor finds an autoimmune disease in need of treatment Drug Discovery News () is an innovative once weekly dual GIP GLP 1 receptor agonist developed for the management of Type 2 Diabetes Mellitus and weight management in appropriate patients. By targeting both GIP and GLP 1 Pilot study 2026: Testosterone add on to tirzepatide restores lean mass in obese hypogonadal late responders Post body: Study: Effects of testosterone undecanoate as add on therapy in obese hypogonadal men that are late Switching from Wegovy to Mounjaro A Comprehensive Guide Best Peptide Stacks: Charts & Protocols PeptidesExplorer Semaglutide and Tirzepatide Dosage Charts: A Complete Guide
Shipping Notes
- Free Standard Shipping on $100+ Orders to the USA.
- Except Preorder products are shipped in 48 hours.
- Delivery to the USA:
- Standard Shipping : 3-10 business days
- If time is of the essence, please consider selecting expedited delivery for faster service.
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
4.2 ★★★★★
Based on 782 reviews
Sort
Product Reviews
★★★★★ 1
PLEASE REVIEW — FORMULA CHANGED!!!
I wish I would’ve posted a review PRIOR to the formula changing but just know that I LOVED this serum. I’ve struggled with hormonal acne (PCOS) and eczema for as long as I can remember. Finally, last summer my dermatologist put me on (3) different RX including Spironolactone and Accutane. I was so tired so I stopped everything except for CeraVe cleanser, retinol (Tretinoin) and CeraVe healing ointment. My made up skin routine was working until I used too much Tretinoin and burned my face. I had read great reviews about this product so I thought, I might as well try it — and IT WORKED! I’ve been using this product for almost a year and I loved it. However, 3 weeks ago when I ordered it, I noticed the bottle had a green tint. I could tell after one use that the feel of the serum was different, more watery, not as thick as it used to be. The smell was also different. Still, I kept using it for nearly 2 weeks and I experienced 2 breakouts! Sure enough, I stopped the product and within a few days, my skin was back to normal. I am very upset because as someone who has extremely sensitive skin, this worked but unfortunately, the new formula isn’t for me.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on May 14, 2026
★★★★★ 5
Great for post microneedling or tattoos
Size: 1.3 Fl Oz (Pack of 1)
Great for skin after microneedling. Keeps skin feeling smooth, non-greasy
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on April 21, 2026
★★★★★ 5
Good on my Melanated skin
Size: 1.3 Fl Oz (Pack of 1)
Lovely, just wish it was bigger or cheaper but I love it and will buy again
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on March 11, 2026
★★★★★ 5
Feels good on the skin not greasy
Size: 1.3 Fl Oz (Pack of 1)
Very nice product very concentrated has a very light fragrance that dissipates very quickly not greasy. No I do not have any redness or sensitivity I wanted to try this product anyway because I'm always looking for moderately priced good quality that travels well. And this fit the bill especially with it being on sale.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on January 8, 2026
★★★★★ 4
Good product , but
Size: 1.3 Fl Oz (Pack of 1), Size: 1.3 Fl Oz (Pack of 1)
It seems to be a good product and it’s not too heavy , but still caused few breakouts here and there . Also, Avenue always has protective foil on their cream , this one didn’t have (I replaced it but new one also didn’t have it). Also, it goes away really fast because it’s only 1.3 ounces.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on April 12, 2026